A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers
about
Transcriptional repression by the insulator protein CTCF involves histone deacetylasesBORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma.Widespread plasticity in CTCF occupancy linked to DNA methylationAnalysis of the vertebrate insulator protein CTCF-binding sites in the human genomeA screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancerPhysical and functional interaction between two pluripotent proteins, the Y-box DNA/RNA-binding factor, YB-1, and the multivalent zinc finger factor, CTCFThe many roles of the transcriptional regulator CTCFEpigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesisThe human enhancer blocker CTC-binding factor interacts with the transcription factor KaisoData interpretation: deciphering the biological function of Type 2 diabetes associated risk loci.Myc oncogene-induced genomic instability: DNA palindromes in bursal lymphomagenesis.CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancerChromatin organization of gammaherpesvirus latent genomes.DNA copy number losses in human neoplasms.Functional phosphorylation sites in the C-terminal region of the multivalent multifunctional transcriptional factor CTCFA review of fluorescence in situ hybridization (FISH): current status and future prospects.Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation.CTCF shapes chromatin by multiple mechanisms: the impact of 20 years of CTCF research on understanding the workings of chromatin.The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancerLoss of maternal CTCF is associated with peri-implantation lethality of Ctcf null embryos.Targeted tumor gene therapy based on loss of IGF2 imprinting.Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stageTherapeutic vaccination with tumor cells that engage CD137.Restraint of angiogenesis by zinc finger transcription factor CTCF-dependent chromatin insulation.Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas.Recurrent genetic aberrations in thymoma and thymic carcinomaPax6 regulation in retinal cells by CCCTC binding factor.Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis.Aspects of molecular phenotype and its correlations with breast cancer behaviour and taxonomy.BORIS, brother of the regulator of imprinted sites, is aberrantly expressed in hepatocellular carcinomaElicitation of T cell responses to histologically unrelated tumors by immunization with the novel cancer-testis antigen, brother of the regulator of imprinted sites.Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.The three-dimensional cancer genome.Agglomerative epigenetic aberrations are a common event in human breast cancer.Vertebrate Protein CTCF and its Multiple Roles in a Large-Scale Regulation of Genome ActivityInterplay between the cancer genome and epigenome.CTCF regulates growth and erythroid differentiation of human myeloid leukemia cells.High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry.CCCTC-binding factor mediates effects of glucose on beta cell survival.Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions
P2860
Q24515375-0EE85C6C-4419-482C-AD07-5376D0D65A00Q24531276-4C5F62C1-65A6-4CF5-A073-CAFCB64B7E13Q24608987-D32EDBF2-38DE-44EC-8CF5-A062056478E5Q24648552-79C7788E-CB9F-4523-878D-0BC0CF9A8EA8Q24794792-1A92FC6D-CE97-416D-A974-C15A9C8213D0Q28141456-88BC47F4-ECB1-43D7-B8DA-AE6465A8469AQ28191705-517053B1-1EB0-4BB5-955B-20E797E28E73Q28264669-D4D34CFD-07B5-47CB-8A3B-C7CBA106516FQ28277466-1B1A80B2-8FDC-40B4-BC21-B747F861633DQ30884322-4F769C66-2D00-4244-8EB5-96043A5EA75FQ33352699-516CE372-42CE-4E2D-A4BE-B1873FD5256AQ33692429-CF4546F3-6C3F-4260-A9BB-688DFFCACDF3Q33729584-7EA46D2A-99A4-4C3F-B3D7-F4295A2861E9Q33733232-CD8701AA-545F-44D5-B117-0FA7A45B7AE5Q33967749-95C828B8-C0D7-4CF6-A5AB-5DBFF389FFBFQ34002217-C940CEC9-5514-4D22-A7D7-A34C1DA957A8Q34005284-6B3A0428-986E-4E21-82EB-DC5851E82928Q34021284-7870C1F1-F34E-4019-9BE6-1B9895354160Q34088277-1956476D-F298-4B28-9599-3E53C3B132C5Q34245001-A2C40213-F9B6-4D9A-BC92-C25F27AFA332Q34581769-9DA6F09A-ECDD-4D79-B67C-84BAC35DAC4EQ34810674-809A8F9C-A8D8-437F-9874-37F9E2A7DBF4Q35071688-6A6F6963-68F8-464D-BB2B-23F5958F7486Q35216918-BF08559E-AEDD-4624-BE58-CC352FFE4F3DQ35745924-548A823F-FFA7-48F2-ADB3-59C3DA7CB8A4Q35745929-A02CA3F2-438B-44C4-B48C-75BF0C7A7224Q35902296-76C06044-042A-47B3-BC17-C2012EE1FAD1Q36017216-9784CA39-1D2B-416E-B910-CC9FA5B68648Q36034197-97B44AA4-3809-48B0-8210-C31B1090CF36Q36553981-2716E6C1-3496-4D7B-9C5F-5A2DF3FCD577Q36649560-F68CC031-FD70-4B8E-ADE4-4BFE30CB2BE3Q36695838-E96DC41C-D970-4D1F-8348-76CB941EDD12Q36936249-6F885F12-BD16-4C90-8752-6AD20C1896B9Q37187180-B0A1610D-E71B-4451-9376-F9F7C6748DD0Q37313422-BF6FF3DB-501F-402D-AF06-B5EE6E3805A4Q38094260-82C870B2-1F3E-44A7-8D70-24CF5FF3ECADQ38325295-84016509-493D-4142-837A-45BBE0AC66D2Q38332865-DD64A660-09F1-40A5-8CAA-683EA3582EE0Q39041874-080880E0-FB5C-4E23-9A05-435A1576133DQ39860615-5BC5F964-DEB7-4628-8B0A-2C9FAC8D2F80
P2860
A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A widely expressed transcripti ...... in breast and prostate cancers
@ast
A widely expressed transcripti ...... in breast and prostate cancers
@en
A widely expressed transcripti ...... in breast and prostate cancers
@en-gb
A widely expressed transcripti ...... in breast and prostate cancers
@nl
type
label
A widely expressed transcripti ...... in breast and prostate cancers
@ast
A widely expressed transcripti ...... in breast and prostate cancers
@en
A widely expressed transcripti ...... in breast and prostate cancers
@en-gb
A widely expressed transcripti ...... in breast and prostate cancers
@nl
prefLabel
A widely expressed transcripti ...... in breast and prostate cancers
@ast
A widely expressed transcripti ...... in breast and prostate cancers
@en
A widely expressed transcripti ...... in breast and prostate cancers
@en-gb
A widely expressed transcripti ...... in breast and prostate cancers
@nl
P2093
P2860
P1476
A widely expressed transcripti ...... in breast and prostate cancers
@en
P2093
E M Klenova
G N Filippova
L J Meincke
N A Doggett
P E Neiman
S J Collins
V V Lobanenkov
P2860
P356
10.1002/(SICI)1098-2264(199805)22:1<26::AID-GCC4>3.0.CO;2-9
P407
P577
1998-05-01T00:00:00Z